NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
National Cancer Policy Forum; Board on Health Care Services; Institute of Medicine; The National Academies of Sciences, Engineering, and Medicine. Assessing and Improving the Interpretation of Breast Images: Workshop Summary. Washington (DC): National Academies Press (US); 2015 Oct 23.
Assessing and Improving the Interpretation of Breast Images: Workshop Summary.
Show detailsSTATEMENT OF TASK
An ad hoc committee will plan and host a 1.5-day public workshop to examine the evidence regarding interpretive performance in breast cancer screening. The workshop will feature panel discussions and invited presentations from experts in the interpretation of screening mammography to assess the state of the evidence, identify remaining gaps, and examine potential opportunities for advancing research and practice.
Participants will be invited to discuss topics related to
- the relationship between reader volume and interpretive performance;
- the relationship between screening and diagnostic volume, and the impact of working up one's own recalled cases on interpretative performance;
- performance criteria to identify radiologists who might benefit most from interventions;
- use of test instruments to assess interpretive performance; and
- tools and interventions to improve interpretive performance.
The committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. An individually authored workshop summary of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
WORKSHOP AGENDA
May 12, 2015
7:45 am | Registration |
8:00 am | Welcome from the National Cancer Policy Forum and the American Cancer Society
|
Overview and Goals of the Workshop
| |
Overview of the 2005 IOM Consensus Report
| |
8:45 am | Session 1: Challenges in the Delivery of High-Quality Mammography
|
Overview of Current Challenges
| |
Geographic Access, Equity, and Impact on Quality
| |
Audits and the National Mammography Database
| |
Group Discussion | |
10:30 am | Break |
10:45 am | Session 2: Training/Experience and Interpretive Performance
|
U.S. and International Variation in Volume and Performance Measures
| |
Interpretive Volume and Accuracy in Canada
| |
The Role of Specialist Radiology Technologists
| |
Residency Requirements and Board Certification and Maintenance
| |
Group Discussion | |
12:30 pm | Lunch Break |
1:15 pm | Session 3: Identifying Radiologists and Facilities That Would Benefit from Intervention
|
Diagnostic and Screening Aspects
| |
Joint Criteria and Confidence Interval-Based Approaches
| |
Identifying Facilities Through CMS Data
| |
Group Discussion | |
3:00 pm | Break |
3:15 pm | Session 4: Test Instruments to Assess Interpretive Performance: Challenges and Opportunities
|
Overview of Test Set Design and Use
| |
Overview of International Test Sets
| |
Panel Discussion:
| |
Group Discussion | |
4:30 pm | Wrap-Up Day 1 and Adjourn |
May 13, 2015
8:00 am | Registration |
8:30 am | Session 5: Tools and Interventions to Improve Interpretive Performance
|
Educational Interventions to Improve Screening
| |
Thresholds for Performance
| |
Panel Discussion:
| |
Group Discussion | |
10:00 am | Break |
10:15 am | Session 6: Reactor Panel: Potential Solutions to Current Challenges
|
Panelists:
| |
Group Discussion | |
11:45 am | Workshop Wrap-Up
|
12:00 pm | Adjourn |
- Statement of Task and Workshop Agenda - Assessing and Improving the Interpretati...Statement of Task and Workshop Agenda - Assessing and Improving the Interpretation of Breast Images
- Workshop Summary - Assessing and Improving the Interpretation of Breast ImagesWorkshop Summary - Assessing and Improving the Interpretation of Breast Images
- PREDICTED: Homo sapiens phosphoglucomutase 5 (PGM5), transcript variant X1, mRNAPREDICTED: Homo sapiens phosphoglucomutase 5 (PGM5), transcript variant X1, mRNAgi|2462625000|ref|XM_054363108.1|Nucleotide
- PREDICTED: Homo sapiens ubiquitin specific peptidase 36 (USP36), transcript vari...PREDICTED: Homo sapiens ubiquitin specific peptidase 36 (USP36), transcript variant X18, mRNAgi|2462556605|ref|XM_054316766.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...